Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Mounjaro (active ingredient: tirzepatide) subcutaneous injection Initial FDA Approval: 2022 Side Effect Update Date: May 28, 2025 Medication Description: Treats type 2 diabetes Updated Side Effects/Safety Information: A new warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting
Prescription GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro are synthetic peptide hormones proven in decades of research and large clinical trials to lower blood sugar and support significant weight loss
Rybelsus dosing: why it starts at 3 mg Rybelsus comes in three tablet strengths: Rybelsus 3 mg, 7 mg, and Rybelsus 14 mg tablets
Temporary numbness or tingling in the vicinity of incisions or persistent or worsening numbness must be reported
Contact your healthcare provider promptly if you experience persistent fasting glucose above 300 mg/dL, symptoms of hyperglycemia (excessive thirst, frequent urination, unexplained weight loss), or if you detect ketones in your urine
US$ 28.90
US$ 29.46
US$ 20.83
US$ 21.83
US$ 27.68
